Dr. Bobby S. Korn, MD

Dr. Korn practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Korn's NPI, 1174551006, was assigned on June 29, 2006. Dr. Korn graduated from UT Southwestern Medical Center in 2001. Dr. Korn holds California license A81749.

Dr. Korn's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Korn's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Korn is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Korn to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Korn practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Korn's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Korn is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Korn is licensed in California.

Dmand AI lists conjunctivitis, dry eye, eyelid inflammation, hypertensive retinopathy and visual impairment and blindness among the conditions Dr. Korn treats.

CMS data shows 984 Medicare services from Dr. Korn across 14 procedure codes in 2024, for 466 Medicare patients. Medicare paid $135,895 for them.

CMS counts 466 Medicare patients who saw Dr. Korn in 2024. The largest group is 65 to 74, with 220 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Korn's median patient age at 64, with 65% women.

In 2024, Dr. Korn wrote 117 Medicare Part D claims for 86 patients. 46% of them were for generic drugs. CMS names the drug for 81 of them, across 1 drug with 11 or more claims each, at $1,009 in total drug cost. In 2023, CMS named 88 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Korn for performance year 2024, reported as part of a group. Dr. Korn accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 160 papers to Dr. Korn, published from 2005 to 2025. 2024 was the busiest year, with 13. The most frequent topics are Orbit, Eyelids and Graves Ophthalmopathy. Dr. Korn has published most often in Ophthalmic Plast Reconstr Surg. Dr. Korn's most frequent co-authors are Don O. Kikkawa, MD, Audrey C. Ko, MD and Lilangi Ediriwickrema, MD.

Dmand AI links Dr. Korn to 1 clinical trial.

CMS Open Payments shows 164 general payments to Dr. Korn from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Amgen Inc. paid the most, $142,465.

Dmand AI lists 10 awards for Dr. Korn, most recently Top Doctors: San Diego Area in 2024.

Dr. Korn graduated from UT Southwestern Medical Center in 2001.

Dr. Korn is in network with 15 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.